Home > Entertainment > Trending Stocks: UltraTech, Dilip Buildcon, HFCL, NTPC and others in news today
opoyicentral
Opoyi Business

3 years ago .

Trending Stocks: UltraTech, Dilip Buildcon, HFCL, NTPC and others in news today

  • Angel One reported a sharply higher profit at Rs 164.54 crore in Q3FY22
  • HFCL reported a lower consolidated profit at Rs 81.1 crore in Q3FY22
  • UltraTech Cement reported a 7.92% rise in its net profit at Rs 1710.14 crore for the quarter under review

Written by:Yash
Published: January 17, 2022 05:33:57

Vikas Ecotech

The company reported a higher profit at Rs 3.42 crore in Q3FY22 against Rs 0.01 crore in Q3FY21, revenue jumped to Rs 75.26 crore from Rs 28.39 crore YoY.

NTPC 

The company is planning to raise a $500 million-plus greenshoe option of $250 million through external commercial borrowing (ECB).

Also Read| PM Modi calls for global cooperation on cryptocurrency

Angel One

The company reported a sharply higher profit at Rs 164.54 crore in Q3FY22 against Rs 73.16 crore in Q3FY21, revenue surged to Rs 597.3 crore from Rs 306.79 crore YoY.

Dilip Buildcon

The four employees who were taken into custody by investigating agency has been released and now nobody from the company is under the custody of investigating agency as of now. The project ‘four laning of Yavatmal to Wardha (Package-III) section of NH-361 under NHDP Phase -IV on Hybrid Annuity mode in Maharashtra’ has been completed.

Also Read| Gold, silver and other metal prices on Tuesday, January 18, 2022

Sonata Software

The company has reported an 81.58% rise in its net profit at Rs 97.67 crore for the quarter under review as compared to Rs 53.79 crore for the same quarter in the previous year. The total income of the company increased by 33.86% at Rs 1873.29 crore for Q3FY22 as compared to Rs 1399.41 crore for the corresponding quarter the previous year.

HFCL 

The company reported a lower consolidated profit at Rs 81.1 crore in Q3FY22 against Rs 85.1 crore in Q3FY21, revenue fell to Rs 1,215.2 crore from Rs 1,277.4 crore YoY.

Also Read| Stock market midday report: Sensex down 96 points, Nifty around 18,200

UltraTech Cement

The company has reported a 7.92% rise in its net profit at Rs 1710.14 crore for the quarter under review as compared to Rs 1584.58 crore for the same quarter in the previous year. The total income of the company increased by 4.26% at Rs 13055.43 crore for Q3FY22 as compared to Rs 12522.03 crore for the corresponding quarter of the previous year.

Strides Pharma Science

The company’s subsidiary Strides Pharma Global Pte Limited, Singapore received USFDA approval for Oseltamivir Phosphate for oral suspension.

Also Read| HFCL share dips nearly 5% after reporting disappointing Q3 results

KEC International 

The company has secured new orders of Rs 1,112 crore across its various businesses.

Tatva Chintan Pharma Chem 

The company reported a higher profit at Rs 22.8 crore in Q3FY22 against Rs 20.87 crore in Q3FY21, revenue jumped to Rs 104.67 crore from Rs 80.1 crore YoY.

Also Read| UltraTech share tanks over 2% despite reporting better than expected Q3 results

Tech Mahindra

The company approved to buy Com Tech Co IT Ltd for 310 million euros and buy a 25% stake each in SWFT Technologies, and Surance.

Axis Bank 

The bank is inching closer to the takeover of Citibank’s India consumer business, with the acquisition deal likely to be finalised this month, news agency Reuters reported on January 17. 

Also Read| Prestige Estates share jumps 8%, touches lifetime high on strong Q3 results

Results on January 18

Bajaj Finance, ICICI Prudential Life Insurance Company, L&T Technology Services, ICICI Securities, Tata Elxsi, Anup Engineering, DCM Shriram, Den Networks, EKI Energy Services, Just Dial, Jyoti Structures, Network18 Media & Investments, Newgen Software Technologies, Ramkrishna Forgings, Shree Ganesh Remedies, Shakti Pumps (India), Star Housing Finance, Trident, and TV18 Broadcast will release quarterly earnings on January 18.

Related Articles

ADVERTISEMENT

© Copyright 2023 Opoyi Private Limited. All rights reserved